We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
AUM
$915M
AUM Growth
-$73.4M
Cap. Flow
-$89.1M
Cap. Flow %
-9.75%
Top 10 Hldgs %
33.03%
Holding
55
New
Increased
1
Reduced
49
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$63.1K

Top Sells

Rank Stock Value
1
PPL
PPL Corp
PPL
+$4.59M
2
T icon
AT&T
T
+$4.05M
3
KO icon
Coca-Cola
KO
+$3.61M
4
D icon
Dominion Energy
D
+$3.31M
5
SBUX icon
Starbucks
SBUX
+$3.19M

Sector Composition

Rank Sector Weight
1 Healthcare 25.76%
2 Utilities 10.08%
3 Energy 9.92%
4 Consumer Staples 9.73%
5 Communication Services 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$442B
$24.1M 2.63%
589,056
-53,035
-8% -$1.96M
SLB icon
27
SLB Ltd
SLB
$78.1B
$23.3M 2.55%
316,382
-20,268
-6% -$1.43M
CVX icon
28
Chevron
CVX
$386B
$23.2M 2.54%
243,340
-19,439
-7% -$1.7M
XOM icon
29
ExxonMobil
XOM
$657B
$22.7M 2.48%
271,740
-22,265
-8% -$1.78M
EOG icon
30
EOG Resources
EOG
$75.1B
$21.5M 2.35%
296,300
-8,983
-3% -$621K
TMO icon
31
Thermo Fisher Scientific
TMO
$223B
$19.7M 2.16%
139,260
-13,454
-9% -$1.8M
JNJ icon
32
Johnson & Johnson
JNJ
$629B
$18.8M 2.06%
174,110
-16,156
-8% -$1.67M
AMGN icon
33
Amgen
AMGN
$225B
$17.8M 1.94%
118,400
-11,893
-9% -$1.77M
ABT icon
34
Abbott
ABT
$192B
$17.5M 1.92%
418,965
-37,642
-8% -$1.49M
CELG
35
DELISTED
Celgene Corp
CELG
$16M 1.74%
159,384
-15,630
-9% -$1.61M
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$3.08M 0.34%
48,300
-23,200
-32% -$1.46M
KHC icon
37
Kraft Heinz
KHC
$29.1B
$1.48M 0.16%
18,800
-6,000
-24% -$449K
ADP icon
38
Automatic Data Processing
ADP
$107B
$1.39M 0.15%
15,500
-6,650
-30% -$557K
LLY icon
39
Eli Lilly
LLY
$1.09T
$1.2M 0.13%
16,700
FE icon
40
FirstEnergy
FE
$27.2B
$1.17M 0.13%
32,500
-15,900
-33% -$534K
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.06M 0.12%
7,500
COST icon
42
Costco
COST
$421B
$867K 0.09%
5,500
-800
-13% -$121K
CL icon
43
Colgate-Palmolive
CL
$73.6B
$862K 0.09%
12,200
-4,800
-28% -$319K
IFF icon
44
International Flavors & Fragrances
IFF
$21.4B
$853K 0.09%
7,500
-2,100
-22% -$235K
SO icon
45
Southern Company
SO
$106B
$833K 0.09%
16,100
-100
-0.6% -$4.87K
GILD icon
46
Gilead Sciences
GILD
$168B
$827K 0.09%
9,000
+700
+8% +$63.1K
ZBH icon
47
Zimmer Biomet
ZBH
$18.7B
$821K 0.09%
7,931
-1,700
-18% -$164K
A icon
48
Agilent Technologies
A
$41.9B
$805K 0.09%
20,200
-8,600
-30% -$328K
AAPL icon
49
Apple
AAPL
$4.41T
$763K 0.08%
28,000
RTX icon
50
RTX Corp
RTX
$300B
$661K 0.07%
10,487
-795
-7% -$46.1K

Similar funds

Stralem & Co's Q1 2016 Portfolio in Review

As of Q1 2016, Stralem & Co held 55 positions worth $915M, down 7.4% from $988M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Stralem & Co withdrew a net $89.1M in Q1 2016, closing 2 positions and reducing 49 holdings. Its most notable exit was NextEra Energy, an estimated $390K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Utilities and Energy.

Against the trend, Stralem & Co added an estimated $63.1K to Gilead Sciences.

  • Stralem & Co added most to Gilead Sciences in Q1 2016, an estimated $63.1K increase.
  • Stralem & Co's biggest Q1 2016 reduction was PPL Corp, cutting an estimated $4.59M.
  • Stralem & Co fully exited NextEra Energy in Q1 2016, selling an estimated $390K.
  • Stralem & Co's ten largest holdings make up 33% of its $915M portfolio in Q1 2016.
  • Stralem & Co opened 0 new positions and closed 2 in Q1 2016.
  • Stralem & Co's portfolio value fell 7.4% quarter-over-quarter to $915M.

Based on Stralem & Co's 13F filing for Q1 2016, filed 18 Apr 2016.